Executives On The Move: Menarini Group Chooses Next CEO, Crescendo Decides On A CBO And Scholar Rock Adds Head, Medical Research
Executive Summary
At Italian Biopharma Menarini Group a former Merck KGaA head of new business is now CEO. Oncology therapeutics firm Crescendo Biologics picks GSK exec as CBO and Biogen medical director is now a Medical Research Head at clinical-stage biopharma Scholar Rock.